X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
LUPIN LTD 2017-18 Annual Report Analysis

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD 2017-18 Annual Report Analysis
Thu, 16 Aug

LUPIN LTD has announced its results for the year ended March 2018. Let us have a look at the detailed performance review of the company during FY17-18.

LUPIN LTD Income Statement Analysis

  • Operating income during the year fell 9.7% on a year-on-year (YoY) basis.
  • The company's operating profit decreased by 29.9% YoY during the fiscal. Operating profit margins witnessed a fall and stood at 19.9% in FY18 as against 25.7% in FY17.
  • Depreciation charges and finance costs increased by 19.0% YoY and 34.0% YoY, respectively.
  • Other income grew by 41.2% YoY.
  • Net profit for the year declined by 90.2% YoY.
  • Net profit margins during the year declined from 14.5% in FY17 to 1.6% in FY18.

LUPIN LTD Income Statement 2017-18

No. of Mths Year Ending 12 Mar-17* 12 Mar-18* % Change
Net Sales Rs m 174,943 158,042 -9.7%
Other income Rs m 1,065 1,504 41.2%
Total Revenues Rs m 176,008 159,545 -9.4%
Gross profit Rs m 44,931 31,475 -29.9%
Depreciation Rs m 9,122 10,859 19.0%
Interest Rs m 1,525 2,044 34.0%
Profit before tax Rs m 35,349 20,076 -43.2%
Tax Rs m 9,785 2,885 -70.5%
Profit after tax Rs m 25,575 2,513 -90.2%
Gross profit margin % 25.7 19.9
Effective tax rate % 27.7 14.4
Net profit margin % 14.5 1.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



LUPIN LTD Balance Sheet Analysis

  • The company's current liabilities during FY18 down at Rs 51 billion as compared to Rs 61 billion in FY17, thereby witnessing an decrease of -16.7%.
  • Long-term debt stood at Rs 64 billion as compared to Rs 56 billion during FY17, a growth of 13.8%.
  • Current assets rose 2% and stood at Rs 122 billion, while fixed assets fell 1% and stood at Rs 130 billion in FY18.
  • Overall, the total assets and liabilities for FY18 stood at Rs 263 billion as against Rs 266 billion during FY17, thereby witnessing a fall of 1%.

LUPIN LTD Balance Sheet as on March 2018

No. of Mths Year Ending 12 Mar-17* 12 Mar-18* % Change
Networth Rs m 134,976 135,771 0.6
 
Current Liabilities Rs m 61,206 50,956 -16.7
Long-term Debt Rs m 56,478 64,245 13.8
Total Liabilities Rs m 266,073 263,054 -1.1
 
Current assets Rs m 119,529 122,095 2.1
Fixed Assets Rs m 131,660 129,876 -1.4
Total Assets Rs m 266,073 263,054 -1.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



LUPIN LTD Cash Flow Statement Analysis

  • LUPIN LTD's cash flow from operating activities (CFO) during FY18 stood at Rs 18 billion on a YoY basis.
  • Cash flow from investing activities (CFI) during FY18 stood at Rs -14 billion on a YoY basis.
  • Cash flow from financial activities (CFF) during FY18 stood at Rs -15 billion on a YoY basis.
  • Overall, net cash flows for the company during FY18 stood at Rs -11 billion from the Rs 20 billion net cash flows seen during FY17.

LUPIN LTD Cash Flow Statement 2017-18

Particulars No. of months 12 12 % Change
Year Ending Mar-17 Mar-18
Cash Flow from Operating Activities Rs m 41,135 17,512 -57.4%
Cash Flow from Investing Activities Rs m -25,274 -14,073 -
Cash Flow from Financing Activities Rs m 4,332 -14,921 -
Net Cash Flow Rs m 20,193 -11,482 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



Current Valuations for LUPIN LTD

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 5.6, an decline from the EPS of Rs 56.6 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 850.6, stands at 27.0 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 3.6 times, while the price to sales ratio stands at 3.1 times.
  • The company's price to cash flow (P/CF) ratio stood at 28.6 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-17* 12 Mar-18*
Sales per share (Unadj.) Rs 387.4 349.6
TTM Earnings per share Rs 56.6 5.6
Diluted earnings per share Rs 56.7 5.6
Price to Cash Flow x 11.1 28.6
TTM P/E ratio x 27.0 27.0
Price / Book Value ratio x 5.2 3.6
Market Cap Rs m 384,114 383,739
Dividends per share (Unadj.) Rs 7.5 5.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



Ratio Analysis for LUPIN LTD

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 2.4x during FY18, from 2.0x during FY17. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 10.8x during FY18, from 24.2x during FY17. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 1.9% during FY18, from 18.9% during FY18. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 3.7% during FY18, from 19.3% during FY17. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 1.7% during FY18, from 10.2% during FY17. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-17* 12 Mar-18*
Current ratio x 2.0 2.4
Debtors’ Days Days 90 120
Interest coverage x 24.2 10.8
Debt to equity ratio x 0.4 0.5
Return on assets % 10.2 1.7
Return on equity % 18.9 1.9
Return on capital employed % 19.3 3.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



To see how LUPIN LTD has performed over the last 5 years, please visit here.

LUPIN LTD Share Price Performance

Over the last one year, LUPIN LTD share price has moved up from Rs 962.2 to Rs 850.6, registering a loss of Rs 111.6 or around 11.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,832.7 (up 1.0%). Over the last one year it has moved up from 13,214.8 to 14,832.7, a gain of 1,618 points (up 12.2%).

Overall, the S&P BSE SENSEX is up 19.8% over the year.

(To know more, check out historical annual results for LUPIN LTD and quarterly results for LUPIN LTD)

Equitymaster requests your view! Post a comment on "LUPIN LTD 2017-18 Annual Report Analysis". Click here!

  

Related Views on News

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD Announces Quarterly Results (1QFY19); Net Profit Up 21.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, LUPIN LTD has posted a net profit of Rs 4 bn (up 21.3% YoY). Sales on the other hand came in at Rs 26 bn (up 3.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LUPIN LTD - STERLING BIOTECH COMPARISON

COMPARE LUPIN LTD WITH

MARKET STATS